Ottley Edward Christopher, Nicholson Helen Diana, Gold Elspeth Joan
Department of Anatomy, University of Otago, Dunedin, New Zealand.
Prostate. 2016 Aug;76(11):951-63. doi: 10.1002/pros.23184. Epub 2016 Mar 28.
Prostate cancer (PCa) is an increasing health issue worldwide. For patients with advanced castration-resistant PCa (CRPC) treatment options are limited and overall survival is relatively short. Paired with this, non-invasive diagnostic options are yet to be established. Activins are members of the TGF-β superfamily and have been linked to prostate physiology. For instance, activin A is an inhibitor of growth in the prostate. A novel class of non-coding RNA, microRNAs (miRNAs) have been intrinsically linked to a range of cellular processes and carcinogenesis. No studies have investigated the impact of activin A on miRNA expression in PCa cell lines. Hence, the objective of this study was to determine the effect of activin A on miRNA expression and downstream target genes in PCa.
Activin-sensitive (LNCaP) and insensitive (PC3) prostate cells were treated with 50 ng/ml of activin A for 72 hr. To examine miRNA expression following treatment, SYBR RT-qPCR miRNA arrays were used in conjunction with TaqMan RT-qPCR. MiRPath-TarBase analysis was conducted using the miRNAs that were significantly altered following activin A treatment of LNCaP cells to highlight enriched target genes within biological pathways. Highlighted target genes were assessed using pathway-focused TGF-β and cell cycle SYBR RT-qPCR arrays.
Activin A treatment altered nine miRNAs in LNCaP cells: miR-222-3p, miR-15b-5p, miR-93-5p, miR-18a-5p, and let-7i-5p were significantly decreased, while miR-30a/30d-5p, let-7c, and miR-196b-5p were significantly increased versus media control. In PC3 cells five miRNAs were altered: miR-130a-3p, miR-7-5p, and miR-140-3p were significantly decreased while miR-191-5p and miR-26a-5p were significantly increased versus media control. MiRPath-TarBase analysis highlighted that the miRNAs significantly altered in LNCaP cells targeted genes contained in activin A-related KEGG pathways. Furthermore, when LNCaP cells were treated with activin A the expression of the targeted genes was the inverse of the expression of activin A-mediated miRNAs.
This study demonstrated the ability of activin A to modulate miRNA expression in PCa cell lines and suggests a correlative relationship between miRNA expression and downstream target genes in LNCaP cells. This study provides impetus for further studies into activin A and miRNAs in PCa. Prostate 76:951-963, 2016. © 2016 Wiley Periodicals, Inc.
前列腺癌(PCa)在全球范围内对健康的影响日益增大。对于晚期去势抵抗性前列腺癌(CRPC)患者,治疗选择有限且总生存期相对较短。与此相伴的是,尚未建立非侵入性诊断方法。激活素是转化生长因子-β(TGF-β)超家族的成员,与前列腺生理功能相关。例如,激活素A是前列腺生长的抑制剂。一类新型非编码RNA,即微小RNA(miRNA),与一系列细胞过程和肿瘤发生存在内在联系。尚无研究调查激活素A对PCa细胞系中miRNA表达的影响。因此,本研究的目的是确定激活素A对PCa中miRNA表达及其下游靶基因的影响。
用50 ng/ml激活素A处理激活素敏感型(LNCaP)和不敏感型(PC3)前列腺细胞72小时。为检测处理后的miRNA表达,将SYBR RT-qPCR miRNA阵列与TaqMan RT-qPCR结合使用。使用激活素A处理LNCaP细胞后显著改变的miRNA进行MiRPath-TarBase分析,以突出生物途径中富集的靶基因。使用聚焦于途径的TGF-β和细胞周期SYBR RT-qPCR阵列评估突出显示的靶基因。
激活素A处理改变了LNCaP细胞中的9种miRNA:与培养基对照相比,miR-222-3p、miR-15b-5p、miR-93-5p、miR-18a-5p和let-7i-5p显著降低,而miR-30a/30d-5p、let-7c和miR-196b-5p显著增加。在PC3细胞中,有5种miRNA发生改变:与培养基对照相比,miR-130a-3p、miR-7-5p和miR-140-3p显著降低,而miR-191-5p和miR-26a-5p显著增加。MiRPath-TarBase分析突出显示,LNCaP细胞中显著改变的miRNA靶向激活素A相关KEGG途径中包含的基因。此外,用激活素A处理LNCaP细胞时靶向基因的表达与激活素A介导的miRNA的表达呈相反关系。
本研究证明了激活素A调节PCa细胞系中miRNA表达的能力,并提示LNCaP细胞中miRNA表达与下游靶基因之间存在相关关系。本研究为进一步研究PCa中的激活素A和miRNA提供了动力。《前列腺》76:951 - 963,2016年。©2016威利期刊公司